BackClimb Bio Overview

Climb Bio Current Assets

Climb Bio's current assets is $210M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$210.15M
↑ 131.02% YoYΔ $119.19M vs prior year quarter

Peer trimmed avg / median

Loading

Climb Bio Current Assets History

Loading

Climb Bio vs. peers: Current Assets Comparison

Loading

Climb Bio Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Climb Bio (CLYM) FAQ

Climb Bio (CLYM) currently reports a current assets of $210M as of September 2026. That compares with $91M in the prior-year period — up 131.0% year over year. Use the charts on this page to explore Climb Bio's current assets history and peer comparisons.

Climb Bio's current assets increased from $91M to $210M — a 131.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Climb Bio reported $210M in current assets as of September 2026. That compares with $91M in the prior-year period — up 131.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Climb Bio, and consider following CLYM for alerts when major investors trade the stock.

Climb Bio is classified in the Healthcare sector. On current assets, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLYM with unrelated industries.